Our Terms of Service and Privacy Policy have changed.

By continuing to use this site, you are agreeing to the new Privacy Policy and Terms of Service.

Pfenex Inc (NYSE American:PFNX)

2.60
Delayed Data
As of 7:59pm ET
 -0.13 / -4.76%
Today’s Change
2.58
Today|||52-Week Range
11.35
-71.33%
Year-to-Date
No recent news for Pfenex Inc.

Today’s Trading

Previous close2.73
Today’s open2.86
Day’s range2.58 - 2.88
Volume123,149
Average volume (3 months)137,941
Market cap$64.2M
Dividend yield--
Data as of 7:59pm ET, 10/16/2017

Growth & Valuation

Earnings growth (last year)--
Earnings growth (this year)-1,008.70%
Earnings growth (next 5 years)--
Revenue growth (last year)+528.13%
P/E ratio37.1
Price/Sales3.57
Price/Book0.80

Competitors

 Today’s
change
Today’s
% change
SRRASierra Oncology Inc+0.04+2.27%
CYTRCytRx Corp-0.01-3.64%
ADMAADMA Biologics Inc+0.01+0.34%
CFRXContraFect Corp-0.05-4.42%
Data as of 4:00pm ET, 10/16/2017

Financials

Next reporting dateNovember 17, 2017
EPS forecast (this quarter)-$0.56
Annual revenue (last year)$60.2M
Annual profit (last year)$5.5M
Net profit margin9.11%

Profile

Sector
Health Technology
Industry
Biotechnology
President, CEO, Secretary &
Director
Evert Schimmelpennink
Chief Medical Officer
Hubert C. Chen
Corporate headquarters
San Diego, California

Forecasts